Ampleye Scleral RGP Lens (roflufocon D, roflufocon E, hexafocon A, paflufocon D)— 510(k) K172314

Substantially Equivalent

Art Optical Contact Lens, Inc.

FDA 510(k) clearance K172314 for Ampleye Scleral RGP Lens (roflufocon D, roflufocon E, hexafocon A, paflufocon D), Substantially Equivalent on 2017-09-20. Applicant: Art Optical Contact Lens, Inc.. Device class: 2.

Clearance details

Applicant
Art Optical Contact Lens, Inc.
Product code
Code HQD
Device class
Class 2
Regulation
21 CFR 886.5916
Advisory panel
Ophthalmic
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Walker, MI, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code HQD

view all

More clearances from Art Optical Contact Lens, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.